WuXi Biologics provides an open-access, integrated technology platform for biologics drug development. WuXi Biologics, a Hong Kong-listed company, is a leading global biologics services provider that offers comprehensive, integrated and highly customizable services. The company offers multinational pharmaceutical and biotechnological companies in the world end-to-end solutions empowering anyone and any company to discover, develop and manufacture biologics from concept to commercial manufacturing. Their services are designed to help their worldwide clients shorten the discovery and development time and lower the cost of biologics.
Specialties: Biologics conjugation, Bioprocess CMC, Biosafety, Biologics GMP Manufacturing, Biologics discovery service, Cell Line Development, Formulation Development, Analytical Characterization, Cell Culture and Purification Process Development, and Monoclonal Antibodies (mAbs)
Labels: Antibody Drug Conjugates, Bispecific Antibodies, Enzymes, Monoclonal Antibodies, Recombinant Protein